US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Jaguar Health, Inc. - Common Stock
(NQ:
JAGX
)
3.660
-0.290 (-7.34%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Jaguar Health, Inc. - Common Stock
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
31 Stocks Moving in Thursday's Pre-Market Session
↗
July 08, 2021
Gainers TESSCO Technologies Incorporated (NASDAQ: TESS) shares rose 46% to $8.41 in pre-market trading after the company reported strong preliminary results for its first quarter...
Via
Benzinga
JAGX Stock: The New Analyst Price Target Making Jaguar Health Jump Today
↗
July 07, 2021
Jaguar Health (JAGX) stock is jumping higher on Wednesday after an analyst initiated coverage of the shares with a positive rating.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2021
↗
July 07, 2021
Upgrades According to Raymond James, the prior rating for Sunnova Energy International Inc (N...
Via
Benzinga
Thinking About Buying Stock In Alibaba, Coinbase Or Jaguar Health?
↗
July 07, 2021
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I...
Via
Benzinga
Why Jaguar Health's Stock Is Trading Lower Today
↗
May 17, 2021
Jaguar Health (NASDAQ:JAGX) shares are trading l...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
July 07, 2021
Gainers Dare Bioscience (NASDAQ:DARE) shares increased by 51.97% to $2.31 during Wednesday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
Jaguar Health Set to Join Russell Microcap Index
June 23, 2021
Jaguar kicks off educational awareness contest about medicinal plants SAN FRANCISCO, CA / ACCESSWIRE / June 23, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that...
From
Jaguar Health, Inc.
Via
AccessWire
Topics
Derivatives
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
June 16, 2021
Gainers Satsuma Pharmaceuticals (NASDAQ:STSA
Via
Benzinga
Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, July 9, 2021 and Encourages All Shareholders to Vote
June 11, 2021
Based on a preliminary review of votes cast, over 76% have voted in favor of Proposals 2, 3, 4 & 6 Meeting scheduled to reconvene July 9, 2021 at 8:30 AM Pacific Standard Time to provide time to reach...
From
Jaguar Health, Inc.
Via
AccessWire
Topics
Regulatory Compliance
24 Stocks Moving in Thursday's Pre-Market Session
↗
June 10, 2021
Gainers Medley Management Inc. (NASDAQ: MDLY) rose 144.9% to $14.30 in pre-market trading after gaining 9% on Wednesday. Medley LLC recently received NYSE notice regarding...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
June 09, 2021
Gainers Enzo Biochem (NYSE:ENZ) stock increa...
Via
Benzinga
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 04, 2021
SAN FRANCISCO, CA / ACCESSWIRE / June 4, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today that effective May 27, 2021, the Company granted nonstatutory stock options...
From
Jaguar Health, Inc.
Via
AccessWire
REMINDER: Innovators with Jane King Webcast Interview with Jaguar Health CEO Lisa Conte & Dragon SPAC Founding Sponsor Josh Mailman to Take Place Thursday, June 3, 2021 at 8:30 AM Eastern
June 02, 2021
Registration link for webcast appears below SAN FRANCISCO, CA / ACCESSWIRE / June 2, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") issued a reminder today that an Innovators with...
From
Jaguar Health, Inc.
Via
AccessWire
JAGX Stock: 2 Big Reasons Jaguar Health Is Climbing Higher Today
↗
June 01, 2021
Today, a variety of factors are taking investors in JAGX stock on a very nice ride, as the company made a couple key announcements.
Via
InvestorPlace
Napo EU S.p.A., Jaguar Health’s Italian Subsidiary, Provides Updates on Plans to Pursue Conditional Marketing Authorization in the EU
June 01, 2021
Jaguar & Dragon SPAC announce initial funding of $10.8 million into Dragon SPAC Napo EU to focus initially on conditional approval for an important orphan indication, short bowel syndrome (SBS), a...
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Health & Dragon SPAC Announce Initial Funding of US$10.8 Million into Dragon SPAC
June 01, 2021
Napo EU S.p.A., named target of Dragon SPAC, provides update on plan to pursue conditional marketing authorization for crofelemer in EU Equita Group S.p.A., a leading Italian based investment bank,...
From
Jaguar Health, Inc.
Via
AccessWire
Topics
Initial Public Offering
Psychedelic Drug Stocks Index -21% In May; Now -25% YTD
↗
May 31, 2021
46 psychedelic drug stocks now trade on the various North American stock exchanges and the 11 with the largest market capitalizations make up the Pure-Play Psychedelic Drug Stocks Index.
Via
Talk Markets
JAGX Stock: Why Jaguar Health Is Climbing Higher Today
↗
May 26, 2021
Investors in JAGX stock are having a solid week, after the company made a few key announcements that have taken this stock higher.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 26, 2021
Gainers Owens & Minor (NYSE:OMI) shares rose 25.47% to $40.66 during Wednesday's regular session. As of 12:31 EST, this security is trading at a volume of 5.4...
Via
Benzinga
Napo Pharmaceuticals, Jaguar Health’s Subsidiary, Bolsters Management Team with Appointment of Darlene Horton, M.D. as Chief Medical Officer
May 26, 2021
SAN FRANCISCO, CA / ACCESSWIRE / May 26, 2021 / Napo Pharmaceuticals Inc., the wholly-owned subsidiary of Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company"), announced today the appointment...
From
Jaguar Health, Inc.
Via
AccessWire
JAGX Stock: Why Jaguar Health Is Soaring on Monday
↗
May 24, 2021
Shares of Jaguar Health and JAGX stock are once again on the move today as investors price in the academic results submitted late last week.
Via
InvestorPlace
Jaguar Health and Napo Pharmaceuticals Provide Key Findings from Cancer-related Diarrhea Abstracts Submitted to ASCO for June 2021 Annual Meeting
May 20, 2021
SAN FRANCISCO, CA / ACCESSWIRE / May 20, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the highlights of the abstract regarding patient outcomes associated with...
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Animal Health (JAGX) Q1 2021 Earnings Call Transcript
↗
May 19, 2021
JAGX earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Jaguar Health Announces the Launch of a New Social Media Channel Dedicated to Reaching the Growing Jaguar Health Community
May 19, 2021
Newly created Jaguar Health Community Instagram page introduces jaguar-themed contest SAN FRANCISCO, CA / ACCESSWIRE / May 19, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company"),...
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Health Provides Updates on Canalevia (Crofelemer), the First Plant-based Prescription Medicine Under Development for Chemotherapy-induced Diarrhea in Dogs and Exercise-induced Diarrhea in Dogs
May 18, 2021
Canalevia would be first and only FDA-approved plant-based medicine for dogs that suffer from diarrhea during chemotherapy Canalevia will be available by fourth quarter 2021, if conditionally approved...
From
Jaguar Health, Inc.
Via
AccessWire
Recap: Jaguar Health Q1 Earnings
↗
May 17, 2021
Shares of Jaguar Health (NASDAQ:JAGX) decreased 1.6% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 83.93% year...
Via
Benzinga
Jaguar Health, Inc. Reports 2021 First Quarter Financial Results
May 17, 2021
First quarter 2021 Mytesi gross sales and net sales were approximately $4.6 million and approximately $1.2 million, increases of 250% and 43%, respectively Company to host investor webcast Monday, May...
From
Jaguar Health, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 14, 2021
SAN FRANCISCO, CA / ACCESSWIRE / May 14, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today that effective May 12, 2021, the Company granted nonstatutory stock options...
From
Jaguar Health, Inc.
Via
AccessWire
Earnings Scheduled For May 17, 2021
↗
May 17, 2021
Companies Reporting Before The Bell • Hycroft Mining Holding (NASDAQ:HYMC) is estimated to report earnings for its first quarter. • U.S. Well Services (NASDAQ:...
Via
Benzinga
Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, June 11, 2021 and Encourages All Shareholders to Vote
May 14, 2021
Based on a preliminary review of votes cast, over 80% have voted in favor of Proposals 2, 3, 4 & 6 Meeting scheduled to reconvene June 11, 2021 at 8:30 AM Pacific Standard Time to provide time to reach...
From
Jaguar Health, Inc.
Via
AccessWire
Topics
Regulatory Compliance
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
